Evidence map›Paper›PMID 30546935›Full record

ArticleJournal of clinical imaging science2018

Comparative Performances of Dipyridamole and Regadenoson to Detect Myocardial Ischemia using Cardiac Cadmium-Zinc-Telluride Single-Photon Emission Computerized Tomography.

Fayçal Ben Bouallçgue, Catherine Nganoa, Jonathan Vigne, Denis Agostini, Alain Manrique

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical imaging science, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Regadenoson versus dipyridamole: Evaluation of stress myocardial blood flow response on a CZT-SPECT camera.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Fayçal Ben BouallçgueDepartment of Nuclear Medicine, Montpellier University Hospital, Caen, France.
Catherine NganoaDepartment of Nuclear Medicine, CHU de Caen, Caen, France.
Jonathan VigneDepartment of Nuclear Medicine, CHU de Caen, Caen, France.
Denis AgostiniDepartment of Nuclear Medicine, CHU de Caen, Caen, France.
Alain ManriqueDepartment of Nuclear Medicine, CHU de Caen, Caen, France.
Université de Caen Normandie · FRCentre Hospitalier Universitaire de Caen · FRUniversité de Montpellier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveWe evaluated the relative performances of dipyridamole (Dip) and regadenoson (Reg) in a cohort of patients referred for coronary artery disease diagnosis or follow-up using myocardial perfusion imaging. MATERIALS AND

methodsWe retrospectively included 515 consecutive patients referred for

resultsQualitative analysis concluded to myocardial ischemia in 70% of the patients (69% in the Dip group, 76% in the Reg group,

conclusionsReg and Dip showed equal performances for ischemic burden characterization using myocardial CZT SPECT.

Indexed as

Cadmium-zinc-telluride cameradipyridamolemyocardial perfusion single-photon emission computerized tomographypharmacologic stressregadenoson

Identifiers

PMID30546935
PMCPMC6251245
OpenAlexW2901226105

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.